Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Leukemia, Biphenotypic, Acute 5Hodgkin Disease 5Burkitt Lymphoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Myeloproliferative Disorders 4Recurrence 3Lymphoma, Non-Hodgkin 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Neuroblastoma 2Myelodysplastic-Myeloproliferative Diseases 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia 2Hematologic Neoplasms 2Transplant-Related Hematologic Malignancy 1Teratoma 1Sarcoma 1Rhabdomyosarcoma 1Neoplasms by Histologic Type 1Neoplasms 1Multi-centric Castleman's Disease 1Macular dystrophy, corneal type 1 1Lymphoproliferative Disorders 1Lymphoma, T-Cell 1

Interventions

Specimen Handling 2Magnetic Resonance Spectroscopy 2Etoposide 2Carboplatin 2pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1Thiotepa 1Standard of Care 1Second-Look Surgery 1Respiratory Physiological Phenomena 1Reoperation 1Radiotherapy 1Radiation 1Practice Guidelines as Topic 1Platinum 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cisplatin 1Bleomycin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Embryonal × Granulocyte Colony-Stimulating Factor × 90 days × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡